These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 838019)

  • 21. Deficient transport mechanism for the removal of acid monoamine metabolites from cerebrospinal fluid.
    Bowers MB
    Brain Res; 1969 Oct; 15(2):522-4. PubMed ID: 5344382
    [No Abstract]   [Full Text] [Related]  

  • 22. Distribution of 5,5 dimethyl-2,4-oxazolidinedione (DMO) in intraocular and cerebrospinal fluids of rabbits. 3. Effect of ammonium chloride and probenecid.
    Constant MA
    Invest Ophthalmol; 1967 Oct; 6(5):484-91. PubMed ID: 6061671
    [No Abstract]   [Full Text] [Related]  

  • 23. Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain?
    Meek JL; Neff NH
    Neuropharmacology; 1973 May; 12(5):497-9. PubMed ID: 4708479
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms for the elimination of 5-hydroxyindoleacetic acid from brain and cerebrospinal fluid of the rat during postnatal development.
    Atack C; Bass NH; Lundborg P
    Brain Res; 1974 Aug; 77(1):111-20. PubMed ID: 4853133
    [No Abstract]   [Full Text] [Related]  

  • 25. 5-hydroxyindoleacetic cid in spinal fluid: relative contribution from brain and spinal cord.
    Weir RL; Chase TN; Ng LK; Kopin IJ
    Brain Res; 1973 Mar; 52():409-12. PubMed ID: 4700720
    [No Abstract]   [Full Text] [Related]  

  • 26. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
    Olsson R; Roos BE
    Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
    [No Abstract]   [Full Text] [Related]  

  • 27. Ultrasonographic anatomy of the atlanto-occipital region and ultrasound-guided cerebrospinal fluid collection in rabbits (Oryctolagus cuniculus).
    Anselmi C; Dias S; Martorell J; Navarro M; Espada Y; Novellas R
    Vet Radiol Ultrasound; 2018 Mar; 59(2):188-197. PubMed ID: 29159974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.
    Korf J; van Praag HM; Sebens JB
    Biochem Pharmacol; 1971 Mar; 20(3):659-68. PubMed ID: 5150161
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors governing the composition of the cerebrospinal fluid.
    Lorenzo AV
    Exp Eye Res; 1977; 25 Suppl():205-28. PubMed ID: 338318
    [No Abstract]   [Full Text] [Related]  

  • 30. Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid levels. A study with and without probenecid administration of their relationship to the state of consciousness after head injury.
    Vecht CJ; van Woerkom CA; Teelken AW; Minderhoud JM
    Arch Neurol; 1975 Dec; 32(12):792-7. PubMed ID: 1203031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid.
    Garelis E; Sourkes TL
    J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):625-9. PubMed ID: 4731331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Similar effects of tryptophan and sleep on cisternal cerebrospinal fluid 5-hydroxyindoleacetic and homovanillic acids in cats.
    Radulovacki M; Buckingham RL; Chen EH; Kovacević R
    Brain Res; 1977 Jul; 129(2):371-4. PubMed ID: 884510
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria.
    Spector R; Lorenzo AV
    J Clin Invest; 1974 Aug; 54(2):316-25. PubMed ID: 4546548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain serotonin, affective illness, and antidepressant drugs: cerebrospinal fluid studies with probenecid.
    Goodwin FK; Post RM
    Adv Biochem Psychopharmacol; 1974; 11(0):341-55. PubMed ID: 4276863
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of probenecid on 5-hydroxyindoles in cerebrospinal fluid in Down's syndrome.
    Airaksinen EM; Kauko K
    Ann Clin Res; 1973 Dec; 5(6):392-4. PubMed ID: 4275983
    [No Abstract]   [Full Text] [Related]  

  • 36. Increase of 5-hydroxyindoleacetic acid and homovanillic acid in cisternal fluid of cats subjected to stress.
    Griauzde M; Radulovacki M
    J Neurochem; 1976 Jun; 26(6):1301-2. PubMed ID: 932735
    [No Abstract]   [Full Text] [Related]  

  • 37. Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.
    Goodwin FK; Post RM; Dunner DL; Gordon EK
    Am J Psychiatry; 1973 Jan; 130(1):73-9. PubMed ID: 4345466
    [No Abstract]   [Full Text] [Related]  

  • 38. On the cerebral origin of 5-hydroxyindoleacetic acid in the lumbar cerebrospinal fluid.
    Bulat M
    Brain Res; 1977 Feb; 122(2):388-91. PubMed ID: 837240
    [No Abstract]   [Full Text] [Related]  

  • 39. Penetration of 5-hydroxyindoleacetic acid across the blood-cerebrospinal fluid barrier.
    Bulat M; Zivković B
    J Pharm Pharmacol; 1973 Feb; 25(2):178-9. PubMed ID: 4146555
    [No Abstract]   [Full Text] [Related]  

  • 40. On the elimination of centrally formed 5-hydroxyindoleacetic acid by cerebrospinal fluid and urine.
    Aizenstein ML; Korf J
    J Neurochem; 1979 Apr; 32(4):1227-33. PubMed ID: 430082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.